OR WAIT null SECS
Agnes Shanley is senior editor of Pharmaceutical Technology.
Research suggests that working with a single contract partner can reduce development time and improve economics.
Competitive pressures have led to explosive growth in demand for research and development (R&D) outsourcing, especially as smaller biopharma and pharmaceutical companies play a more prominent role in drug development. Pharmaceutical manufacturers, especially small- to mid-sized companies, are discovering that partnering more closely with one diversified contract company can reduce development time and cost.
Read this article in BioPharm International'sOutsourcing Resources 2018 eBook.
View other articles in BioPharm International's Outsourcing Resources 2018 eBook.
eBook: Outsourcing Resources 2018
When referring to this article, please cite it as A. Shanley, “Outsourcing: Does Focus Pay Off?," BioPharm International Outsourcing Resources eBook (March 2018).